Trulieve Cannabis (TCNNF) Current Deferred Revenue (2020 - 2026)
Trulieve Cannabis has reported Current Deferred Revenue over the past 6 years, most recently at $9.6 million for Q4 2025.
- For Q4 2025, Current Deferred Revenue rose 19.49% year-over-year to $9.6 million; the TTM value through Dec 2025 reached $9.6 million, up 19.49%, while the annual FY2025 figure was $9.6 million, 19.49% up from the prior year.
- Current Deferred Revenue for Q4 2025 was $9.6 million at Trulieve Cannabis, up from $8.9 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $9.6 million in Q4 2025 and troughed at $1.3 million in Q4 2023.
- A 5-year average of $6.2 million and a median of $6.4 million in 2022 define the central range for Current Deferred Revenue.
- Biggest five-year swings in Current Deferred Revenue: tumbled 85.89% in 2023 and later soared 501.35% in 2024.
- Year by year, Current Deferred Revenue stood at $6.7 million in 2021, then skyrocketed by 41.18% to $9.5 million in 2022, then tumbled by 85.89% to $1.3 million in 2023, then soared by 501.35% to $8.0 million in 2024, then grew by 19.49% to $9.6 million in 2025.
- Business Quant data shows Current Deferred Revenue for TCNNF at $9.6 million in Q4 2025, $8.9 million in Q3 2025, and $8.4 million in Q2 2025.